Related Experiment Video
Updated: Jun 15, 2026

11:01
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
Sorting out drug-eluting stents
Mark W I Webster1, John A Ormiston
1Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand. mwebster@adhb.govt.nz
Lancet (London, England)
|March 17, 2010
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Non-contact quantification of aortic stenosis and mitral regurgitation using carotid waveforms from skin displacements.
Physiological measurement·2023
Same author
The Polyzene-F Stent Coating Improves Healing and Outcomes Preclinically, but Is It Effective Clinically?
Cardiovascular revascularization medicine : including molecular interventions·2022
Same author
Proximal to Distal Y-Stent Deployment for Coronary Bifurcation Lesions: Procedure and Three-Year Clinical Outcomes.
The Journal of invasive cardiology·2022
Same author
Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2021
Same author
Management of Coronary Disease in Patients with Advanced Kidney Disease.
The New England journal of medicine·2020
Same author
Surgical repair after failed thoracic endovascular aortic repair for severe blunt traumatic descending thoracic aorta injury in a young patient.
ANZ journal of surgery·2020
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
